Kobayashi Pharmaceutical Scandal Threatens 33,000 Japanese Enterprises
An investigation reveals that Kobayashi Pharmaceutical’s red yeast rice products may impact up to 33,000 enterprises in Japan, following health concerns and product recalls.
News & Insights Across Asia
An investigation reveals that Kobayashi Pharmaceutical’s red yeast rice products may impact up to 33,000 enterprises in Japan, following health concerns and product recalls.
The China Consumers Association has warned consumers to stop using certain Japanese red yeast rice supplements after reports of deaths and hospitalizations, urging caution with cross-border health products.